• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Measuring utility values of eye conditions among children in India using the EQ-5D-Y instrument.使用EQ-5D-Y工具测量印度儿童眼部疾病的效用值。
Health Econ Rev. 2024 Sep 7;14(1):72. doi: 10.1186/s13561-024-00552-0.
2
Health Utility Values Among Patients With Diabetic Retinopathy, Wet Age-Related Macular Degeneration, and Cataract in Thailand: A Multicenter Survey Using Time Trade-Off, EQ-5D-5L, and Health Utility Index 3.泰国糖尿病视网膜病变、湿性年龄相关性黄斑变性和白内障患者的健康效用值:使用时间权衡、EQ-5D-5L 和健康效用指数 3 的多中心调查
Value Health Reg Issues. 2024 Nov;44:101030. doi: 10.1016/j.vhri.2024.101030. Epub 2024 Jul 31.
3
Health-related quality of life among Indian population: The EQ-5D population norms for India.印度人群的健康相关生活质量:印度 EQ-5D 人群正常值。
J Glob Health. 2023 Feb 17;13:04018. doi: 10.7189/jogh.13.04018.
4
Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?采用通用的欧洲五维健康量表问卷测量的慢性阻塞性肺疾病(COPD)患者的生活质量能否区分COPD的严重程度阶段?
Chest. 2006 Oct;130(4):1117-28. doi: 10.1378/chest.130.4.1117.
5
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.使用通用和特定疾病健康相关生活质量测量指标进行 NICE 决策制定:系统评价、统计建模和调查。
Health Technol Assess. 2014 Feb;18(9):1-224. doi: 10.3310/hta18090.
6
Measurement properties of the EQ-5D-Y administered through a smartphone app in children with asthma: a longitudinal questionnaire study.哮喘儿童通过智能手机应用程序使用 EQ-5D-Y 的测量性能:纵向问卷调查研究。
Health Qual Life Outcomes. 2022 Mar 28;20(1):51. doi: 10.1186/s12955-022-01955-5.
7
Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.使用EQ-5D-5L量表测量的健康相关生活质量:南澳大利亚州人群常模。
Health Qual Life Outcomes. 2016 Sep 20;14(1):133. doi: 10.1186/s12955-016-0537-0.
8
Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study.在线欧洲五维健康量表-青少年版在1型糖尿病儿童和青少年中的测量属性:问卷调查研究
J Med Internet Res. 2019 Nov 12;21(11):e14947. doi: 10.2196/14947.
9
Indonesia youth population norms for EQ-5D-Y-3 L, EQ-5D-Y-5 L and the PedsQL generic core scale: lower health related quality of life relates to high economic status and stress.印度尼西亚青年人群 EQ-5D-Y-3L、EQ-5D-Y-5L 和 PedsQL 通用核心量表的正常值:健康相关生活质量较低与较高的经济地位和压力有关。
BMC Public Health. 2023 Jun 12;23(1):1124. doi: 10.1186/s12889-023-16003-0.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

本文引用的文献

1
Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.基于离散选择实验(DCE)到时间权衡(TTO)值的映射来估计印度尼西亚的 EQ-5D-Y-3L 值集。
Pharmacoeconomics. 2022 Dec;40(Suppl 2):157-167. doi: 10.1007/s40273-022-01210-1. Epub 2022 Nov 9.
2
The economic and social costs of visual impairment and blindness in India.印度视力障碍和失明的经济和社会成本。
Indian J Ophthalmol. 2022 Oct;70(10):3470-3475. doi: 10.4103/ijo.IJO_502_22.
3
Current estimates of the economic burden of blindness and visual impairment in India: A cost of illness study.目前印度失明和视力损害经济负担的估计:疾病成本研究。
Indian J Ophthalmol. 2022 Jun;70(6):2141-2145. doi: 10.4103/ijo.IJO_2804_21.
4
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.30 多年来盲症和远距离及近距离视力损伤流行率的变化趋势:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e130-e143. doi: 10.1016/S2214-109X(20)30425-3. Epub 2020 Dec 1.
5
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.2020 年失明和视力障碍的原因及 30 多年来的趋势,以及与 VISION 2020:看见的权利相关的可避免盲的患病率:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
6
Mapping From Visual Acuity to EQ-5D, EQ-5D With Vision Bolt-On, and VFQ-UI in Patients With Macular Edema in the LEAVO Trial.LEAVO 试验中黄斑水肿患者的视力到 EQ-5D、带视觉附加模块的 EQ-5D 以及 VFQ-UI 的映射。
Value Health. 2020 Jul;23(7):928-935. doi: 10.1016/j.jval.2020.03.008. Epub 2020 Jun 2.
7
Commentary: Rapid assessment of avoidable blindness and diabetic retinopathy in India.评论:印度可避免失明和糖尿病视网膜病变的快速评估
Indian J Ophthalmol. 2020 Feb;68(2):381-382. doi: 10.4103/ijo.IJO_1133_19.
8
Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results.基于不同国家价值集比较EQ-5D-5L效用指数:对临床研究结果解释的影响
BMC Res Notes. 2019 Jan 14;12(1):18. doi: 10.1186/s13104-019-4067-9.
9
Commentary: Childhood blindness in India: Regional variations.评论:印度儿童失明情况:地区差异
Indian J Ophthalmol. 2018 Oct;66(10):1461-1462. doi: 10.4103/ijo.IJO_1144_18.
10
Emerging trends in childhood blindness and ocular morbidity in India: the Pavagada Pediatric Eye Disease Study 2.印度儿童失明和眼部疾病的新趋势:帕瓦加达儿童眼病研究2
Eye (Lond). 2018 Oct;32(10):1590-1598. doi: 10.1038/s41433-018-0142-z. Epub 2018 Jun 11.

使用EQ-5D-Y工具测量印度儿童眼部疾病的效用值。

Measuring utility values of eye conditions among children in India using the EQ-5D-Y instrument.

作者信息

Mannava Sunny, Borah Rishi Raj, Shamanna B R

机构信息

School of Medical Sciences, University of Hyderabad, C.R. Rao Road, Gachibowli, Hyderabad, 500046, Telangana, India.

Country Director, Orbis India Country Office, MG Road, Gurugram, 122002, Haryana, India.

出版信息

Health Econ Rev. 2024 Sep 7;14(1):72. doi: 10.1186/s13561-024-00552-0.

DOI:10.1186/s13561-024-00552-0
PMID:39242433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11380325/
Abstract

BACKGROUND

Vision impairment and blindness are significant global public health challenges, particularly in low- and middle-income countries, where access to eye care services remains limited. India has significantly reduced the prevalence of Blindness and Vision Impairment (VI) over the last two decades. This was achieved with the help of greater investments towards blindness control programs. The use of utility values helps in conducting economic evaluations of various eye health programs and empirically justify investing in these programs. This study aimed to estimate utility values for various childhood eye conditions in central India using the EuroQol-Five-Dimension-Youth (EQ-5D-Y) instrument.

METHODS

This is a before and after study with data collected at two time points for few participants and at only one time point for others. This study was undertaken at Shri Sadguru Netra Chikitsalaya (SNC) and included children representing central and north India. Participants were randomly sampled in the hospital. After comprehensive eye examination, participants completed the EuroQol-Five-Dimension-Youth (EQ-5D-Y) questionnaire along with EuroQol Visual Analogue Scale (EQ VAS) measurement to elicit their health state for their condition which was repeated after six months post-intervention to measure the change in utility value. We have used Indonesian value set to analyze the preference scores of each dimension of EQ-5D-Y.

RESULTS

Utility values of 16 eye conditions were estimated at baseline and seven conditions were followed up for post-intervention utility value estimation. There is a statistically significant improvement in the utility values post-intervention amongst six conditions. Blindness and Pediatric cataract had the greatest change (0.23 and 0.2 respectively) in utility value whereas mild Vision Impairment (VI) showed the least change (0.02) in the utility value post-intervention. Blindness had the lowest baseline (0.62) and post-intervention (0.85) utility value.

CONCLUSION

The utility values estimated in this study showed that generic measures such as EQ-5D-Y may be used to elicit health states for various eye conditions amongst children. These estimates are helpful in undertaking cost-utility analyses of eye health programs and interventions aimed at these eye conditions.

摘要

背景

视力损害和失明是重大的全球公共卫生挑战,在中低收入国家尤为如此,这些国家获得眼保健服务的机会仍然有限。在过去二十年里,印度显著降低了失明和视力损害(VI)的患病率。这是通过对失明控制项目增加投资实现的。使用效用值有助于对各种眼保健项目进行经济评估,并从经验上证明对这些项目进行投资的合理性。本研究旨在使用欧洲五维度青少年健康量表(EQ-5D-Y)工具估计印度中部各种儿童眼部疾病的效用值。

方法

这是一项前后对照研究,部分参与者在两个时间点收集数据,其他参与者仅在一个时间点收集数据。本研究在什里·萨古鲁眼科医院(SNC)进行,纳入了代表印度中部和北部的儿童。参与者在医院进行随机抽样。经过全面的眼科检查后,参与者完成欧洲五维度青少年健康量表(EQ-5D-Y)问卷以及欧洲五维度视觉模拟量表(EQ VAS)测量,以得出他们当前健康状况的效用值,并在干预后六个月重复测量以评估效用值的变化。我们使用印度尼西亚效用值集来分析EQ-5D-Y各维度的偏好得分。

结果

在基线时估计了16种眼部疾病的效用值,其中7种疾病在干预后进行了效用值随访评估。六种疾病在干预后的效用值有统计学上的显著改善。失明和儿童白内障的效用值变化最大(分别为0.23和0.2),而轻度视力损害(VI)在干预后的效用值变化最小(0.02)。失明的基线效用值(0.62)和干预后效用值(0.85)最低。

结论

本研究估计的效用值表明,诸如EQ-5D-Y等通用测量方法可用于得出儿童各种眼部疾病的健康状况。这些估计值有助于对针对这些眼部疾病的眼保健项目和干预措施进行成本效用分析。